CA Patent

CA2732440C — Cystamine analogues for the treatment of parkinson`s disease

Assigned to Universite Laval · Expires 2017-10-31 · 9y expired

What this patent protects

The present invention relates to the use of cystamine analogues for the treatment of Parkinson's disease. The present invention also relates to the use of composition comprising cystamine analogues and cysteine.

USPTO Abstract

The present invention relates to the use of cystamine analogues for the treatment of Parkinson's disease. The present invention also relates to the use of composition comprising cystamine analogues and cysteine.

Drugs covered by this patent

cysteamine-bitartrate (CYSTEAMINE BITARTRATE)

Patent Metadata

Patent number: CA2732440C
Jurisdiction: CA
Classification: —
Expires: 2017-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Universite Laval
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.